The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
Abstract
Purpose To describe the effect of atrial fibrillation on long-term morbidity and mortality.Subjects and methods The Renfrew/Paisley Study surveyed 7052 men and 8354 women aged 45-64 years between 1972 and 1976. All hospitalizations and deaths occurring during the subsequent 20 years were analyzed by the presence or absence of atrial fibrillation at baseline. Lone atrial fibrillation was defined in the absence of other cardiovascular signs or symptoms. Cox proportional hazards models were used to adjust for age and cardiovascular conditions.Results After 20 years, 42 (89%) of the 47 women with atrial fibrillation had a cardiovascular event (death or hospitalization), compared with 2276 (27%) of the 8307 women without this arrhythmia. Among men, 35 (66%) of 53 with atrial fibrillation had an event, compared with 3151 (45%) of 6999 without atrial fibrillation. In women, atrial fibrillation was an independent predictor of cardiovascular events (rate ratio [RR] = 3.0; 95% confidence interval [CI]: 2.1-4.2), fatal or nonfatal strokes (RR = 3.2; 95% CI: 1.0-5.0), and heart failure (RR = 3.4; 95% CI: 1.9-6.2). The rate ratios among men were 1.8 (95% CI: 1.3-2.5) for cardiovascular events, 2.5 (95% CI: 1.3-4.8) for strokes, and 3.4 (95% CI: 1.7-6.8) for heart failure. Atrial fibrillation was an independent predictor of all-cause mortality in women (RR = 2.2; 95% CI: 1.5-3.2) and men (RR = 1.5; 95% CI: 1.2-2.2). However, lone atrial fibrillation (which occurred in 15 subjects) was not associated with a statistically significant increase in either cardiovascular events (RR = 1.5; 95% CI: 0.6-3.6) or mortality (RR = 1.8; 95% CI: 0.9-3.8).Conclusions Atrial fibrillation is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality, especially in women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a rabbit model, left atrial and pulmonary vein tissue from females displayed longer action potential duration, and female pulmonary vein tissue had a more negative resting membrane potential compared with males.147”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [147]
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Epidemiologic Features of Chronic Atrial Fibrillation
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061703 · Cited by 2,304
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033
Petersen, P., GODTFREDSEN, J., Boysen, G., Andersen, E. D., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,814
Lüderitz, B. (1999) · Journal of interventional cardiac electrophysiology · doi:10.1023/a:1009863214233 · Cited by 1,709
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,636
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators* (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,525
Krahn, A. D., Manfreda, J., TATE, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478
Research works printed but not linked: 2
- 1965, Definition and classification of chronic bronchitis for epidemiological purposes, Lancet, i, 775
- Clarke, 1994, Evidence of inadequate investigation and treatment of patients with heart failure, Br Heart J, 71, 584, 10.1136/hrt.71.6.584 · DOI
Cited by
Sorted by citations
Items 201–300 of 1,000
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A. M., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T., et al. (2021) · Global Heart · doi:10.5334/gh.1023 · Cited by 95
Mechanisms of persistent atrial fibrillation
Jalife, J. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000027 · Cited by 89
Lip, G. Y. H., Kongnakorn, T., Phatak, H. M., Kuznik, A., Lanitis, T., Liu, L. Z., Iloeje, U. H., Hernandez, L. G., & Dorian, P. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.12.011 · Cited by 88
Association Between Atrial Fibrillation and Sudden Cardiac Death
Waldmann, V., Jouven, X., Narayanan, K., Piot, O., Chugh, S. S., Albert, C. M., & Marijon, É. (2020) · Circulation Research · doi:10.1161/circresaha.120.316756 · Cited by 91
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente‐Lafuente, C., Longás-Tejero, M. A., Bergmann, J., & Belmin, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub3 · Cited by 90
Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China
Li, X., Gao, L., Wang, Z., Guan, B., Guan, X., Wang, B., Han, X., Xiao, X., Waleed, K. B., Chandran, C., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.22864 · Cited by 85
Kim, Y. G., Han, K., Choi, J., Boo, K. Y., Kim, D. Y., Oh, S., Lee, K., Shim, J., Kim, J. S., & Kim, Y. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0932-z · Cited by 85
Goldenthal, I. L., Sciacca, R. R., Riga, T. C., Henry, S. B., Baumeister, M., BIVIANO, A. B., Dizon, J. M., Wang, D., Wang, K. C., Whang, W., et al. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14160 · Cited by 84
Atrial fibrillation: A major risk factor for cognitive decline
Hui, D. S., Morley, J. E., Mikolajczak, P. C., & Lee, R. (2015) · American Heart Journal · doi:10.1016/j.ahj.2014.12.015 · Cited by 84
Eranti, A., Aro, A. L., Kerola, T. V., Anttonen, O. M., Rissanen, H. A., Tikkanen, J. T., Junttila, J. M., Kenttä, T. V., Knekt, P., & Huikuri, H. V. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001557 · Cited by 83
Boelaert, K., Maisonneuve, P., Torlinska, B., & Franklyn, J. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3459 · Cited by 82
Yoon, Y. E., Oh, I., Kim, S., Park, K.-H., Kim, S. H., Park, J., Kim, J.-E., Lee, S., Kim, H., Kim, Y.-J., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.01.017 · Cited by 82
Enriquez, A. A., Conde, D. G., Hopman, W. M., Mondragón, I., Chiale, P. A., de Luna, A. B., & Baranchuk, A. M. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12063 · Cited by 83
Stone, D. L., Byrne, T., & Pershad, A. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25065 · Cited by 80
Bishop, M. J., Rajani, R., Plank, G., Gaddum, N. R., Carr‐White, G., Wright, M. J., O'Neill, M. D., & Niederer, S. (2015) · EP Europace · doi:10.1093/europace/euv073 · Cited by 81
Phased RF ablation in persistent atrial fibrillation
Hummel, J. D., Michaud, G. F., HOYT, R. H., DeLurgio, D. B., Rasekh, A., Kusumoto, F. M., GIUDICI, M. C., Dan, D., Tschopp, D. R., Calkins, H. G., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.11.009 · Cited by 80
Left Atrial Mechanical Function and Stiffness in Patients with Paroxysmal Atrial Fibrillation
Yoon, Y. E., Kim, H., Kim, S., Kim, S. H., Park, J., Park, K.-H., Choi, S., Kim, M.-K., Kim, H., & Cho, G. (2012) · Journal of Cardiovascular Ultrasound · doi:10.4250/jcu.2012.20.3.140 · Cited by 80
Hansen, B. M., Nilsson, O., Anderson, H., Norrving, B. G., Säveland, H., & Lindgren, A. G. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305200 · Cited by 80
A Missense Variant in PLEC Increases Risk of Atrial Fibrillation
Þórólfsdóttir, R. B., Sveinbjörnsson, G., Sulem, P., Helgadóttir, A., Grétarsdóttir, S., Benónísdóttir, S., Magnusdottir, A., Davidsson, O. B., Rajamani, S., Roden, D. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.005 · Cited by 77
Sandhu, R. K., Bakal, J. A., Ezekowitz, J. A., & McAlister, F. A. (2011) · Heart · doi:10.1136/heartjnl-2011-300901 · Cited by 79
Zhang, Z., Zhang, X., Meng, L., Gong, M., Li, J., Shi, W., Qiu, J., Yang, Y., Zhao, J., Suo, Y., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.658362 · Cited by 79
Rodgers, M., McKenna, C., Palmer, S., Chambers, D., Hout, S. V., Golder, S., Pepper, C., TODD, D. M., & Woolacott, N. F. (2008) · Health Technology Assessment · doi:10.3310/hta12340 · Cited by 79
Birth Weight Is a Significant Risk Factor for Incident Atrial Fibrillation
Conen, D., Tedrow, U. B., Cook, N. R., Buring, J. E., & Albert, C. M. (2010) · Circulation · doi:10.1161/circulationaha.110.947978 · Cited by 79
Tiwari, S., Schirmer, H., Jacobsen, B. K., Hopstock, L. A., Nyrnes, A., Heggelund, G., Njølstad, I., Mathiesen, E. B., & Løchen, M. (2015) · Heart · doi:10.1136/heartjnl-2015-307438 · Cited by 79
Tsang, T. S. M., & Gersh, B. J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01245-7 · Cited by 79
Chrispin, J., Jain, A., Soliman, E. Z., Güallar, E., Alonso, Á., Heckbert, S. R., Bluemke, D. A., Lima, J. A. C., & Nazarian, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.066 · Cited by 77
Novo, G., Guttilla, D., Fazio, G., Cooper, D., & Novo, S. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03234.x · Cited by 80
Bilato, C., Corti, M., Baggio, G., Rampazzo, D., Cutolo, A., Iliceto, S., & Crepaldi, G. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.058 · Cited by 78
Diamantopoulos, A., Sawyer, L., Lip, G. Y. H., Witte, K. K., Reynolds, M. R., Fauchier, L., Thijs, V., Brown, B., Angulo, M. E. Q., & Diener, H. (2016) · International Journal of Stroke · doi:10.1177/1747493015620803 · Cited by 78
Guan, B., Li, X., Xue, W.-Q., Tse, G., Waleed, K. B., Liu, Y., Zheng, M., Wu, S., Xia, Y., & Ding, Y. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.12.002 · Cited by 80
An International View of How Recent‐onset Atrial Fibrillation Is Treated in the Emergency Department
Rogenstein, C., Kelly, A., Mason, S. M., Schneider, S. M., Lang, E., Clement, C. M., & Stiell, I. G. (2012) · Academic Emergency Medicine · doi:10.1111/acem.12016 · Cited by 77
Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels
Ogunsua, A., Shaikh, A. Y., Ahmed, M., & McManus, D. D. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-4-228 · Cited by 80
Long-term Use of Anti-inflammatory Drugs and Risk of Atrial Fibrillation
Caterina, R. D., Ruigómez, A., & Rodríguez, L. A. G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.305 · Cited by 75
Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications
Linz, D., Linz, B. M., Hohl, M., & Böhm, M. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.03.003 · Cited by 76
Raunsø, J., Selmer, C., Olesen, J. B., Charlot, M. G., Olsen, A. S., Bretler, D., Nielsen, J. D., Domínguez, H., Gadsbøll, N., Køber, L., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr454 · Cited by 74
Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment
Hakalahti, A., Uusimaa, P., Ylitalo, K. V., & Raatikainen, M. J. P. (2011) · EP Europace · doi:10.1093/europace/eur038 · Cited by 74
Hanon, O., Assayag, P., Belmin, J., Collet, J., Émeriau, J. P., Fauchier, L., Forette, F., Friocourt, P., Gentric, A., Leclercq, C., et al. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.04.001 · Cited by 72
Crandall, M. A., Horne, B. D., DAY, J. D., Anderson, J. L., Muhlestein, J. B., Crandall, B. G., Weiss, J. P., OSBORNE, J. S., LAPPE, D. L., & Bunch, T. J. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02427.x · Cited by 74
Prevalence of atrial fibrillation and its risk factors in rural China: A cross-sectional study
Sun, G., Guo, L., Wang, X., Song, H., Li, Z., Wang, J., & Sun, Y. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.063 · Cited by 73
Coronary Ischemic Events after First Atrial Fibrillation: Risk and Survival
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Seward, J. B., Iwasaka, T., & Tsang, T. S. M. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.042 · Cited by 74
eHealth in cardiovascular medicine: A clinical update
Saner, H. E., & van der Velde, E. T. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316670256 · Cited by 79
Shields, A. M., & Lip, G. Y. H. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12360 · Cited by 72
Struthers, A. D., & Lang, C. C. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm234 · Cited by 72
Benzimra, M., Bonnamour, B., Duracinský, M., Lalanne, C., Aubert, J.-P., Chassany, O., Aubin-Auger, I., & Mahé, I. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s131158 · Cited by 74
Zuo, K., Li, J., Wang, P., Liu, Y., Liu, Z., Yin, X., Liu, X., & Yang, X. (2019) · mSystems · doi:10.1128/msystems.00422-19 · Cited by 71
Atrial fibrillation in chronic non-cardiac disease: Where do we stand?
Lainščak, M., Dagres, N., Filippatos, G. S., Anker, S. D., & Kremastinos, D. T. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.078 · Cited by 69
Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction
Linz, D., Hohl, M., Vollmar, J., Ukena, C., Mahfoud, F., & Böhm, M. (2016) · EP Europace · doi:10.1093/europace/euw092 · Cited by 72
Management of Atrial Fibrillation in Critically Ill Patients
Arrigo, M., Béttex, D., & Rudiger, A. (2014) · Critical Care Research and Practice · doi:10.1155/2014/840615 · Cited by 71
Induction of Atrial Fibrillation by Neutrophils Critically Depends on CD11b/CD18 Integrins
Friedrichs, K. P., Adam, M., Remane, L., Mollenhauer, M., Rudolph, V., Rudolph, T. K., Andrié, R., Stöckigt, F., SCHRICKEL, J. W., Ravekes, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089307 · Cited by 69
Rivard, L., & Khairy, P. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.09.024 · Cited by 70
Sethi, N. J., Feinberg, J. B., Nielsen, E. E., Safi, S., Gluud, C. N., & Jakobsen, J. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186856 · Cited by 75
Andersson, T., Magnuson, A., Bryngelsson, I.-L., Frøbert, O., Henriksson, K. M., Edvardsson, N., & Poçi, D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.092 · Cited by 68
Telmisartan: A Different Angiotensin II Receptor Blocker Protecting a Different Population?
Burnier, M. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700602 · Cited by 69
Ittermann, T., Haring, R., Sauer, S., Wallaschofski, H., Dörr, M., Nauck, M. A., & Völzke, H. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0566 · Cited by 68
Ceresini, G., Ceda, G. P., Lauretani, F., Maggio, M., Usberti, E., Marina, M., Bandinelli, S., Guralnik, J. M., Valenti, G., & Ferrucci, L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12267 · Cited by 67
Left Atrial Structure and Function and the Risk of Death or Heart Failure in Atrial Fibrillation
Inciardi, R. M., Giugliano, R. P., Claggett, B. L., Gupta, D. K., Chandra, A., Ruff, C. T., Antman, E. M., Mercuri, M. F., GROSSO, M. A., D, E. B. M., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1606 · Cited by 67
Mortality in atrial fibrillation. Is it changing?
Alonso, Á., Almuwaqqat, Z., & Chamberlain, A. M. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.10.010 · Cited by 67
The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation
Letsas, Κ. P., Herrera‐Siklody, C., Korantzopoulos, P. G., Weber, R., Bürkle, G., Mihas, C. C., Kalusche, D., & Arentz, T. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.092 · Cited by 67
The atrial fibrillation knowledge scale: Development, validation and results
Hendriks, J., Crijns, H. J. G. M., Tieleman, R. G., & Vrijhoef, H. J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.047 · Cited by 67
Smart, N. A., King, N., Lambert, J. D., Pearson, M. J., Campbell, J. L., Risom, S. S., & Taylor, R. S. (2018) · Open Heart · doi:10.1136/openhrt-2018-000880 · Cited by 69
Bansal, N., Xie, D., Sha, D., Appel, L. J., Deo, R., Feldman, H. I., He, J., Jamerson, K., Kusek, J. W., Messe, S. R., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018050514 · Cited by 69
Epidemiology of Atrial Fibrillation and Heart Failure
Karnik, A. A., Gopal, D. M., Ko, D., Benjamin, E. J., & Helm, R. H. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.01.001 · Cited by 66
Patel, R. B., Vaduganathan, M., Shah, S. J., & Butler, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.019 · Cited by 68
Andrew, N. E., Thrift, A. G., & Cadilhac, D. A.-M. (2013) · Neuroepidemiology · doi:10.1159/000343667 · Cited by 66
Cardiac Arrythmias: Multimodal Assessment Integrating Body Surface ECG Mapping into Cardiac Imaging
Cochet, H., Dubois, R., Sacher, F., Derval, N., Maxime Sermesant, B., Hocini, M., Montaudon, M., Haı̈ssaguerre, M., Laurent, F., & Jaı̈s, P. (2013) · Radiology · doi:10.1148/radiol.13131331 · Cited by 65
Lee, R. J., & Mittal, S. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.009 · Cited by 65
Al-Omari, M. A., Finstuen, J. A., Appleton, C. P., Barnes, M. E., & Tsang, T. S. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.067 · Cited by 64
Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation
Perino, A. C., Fan, J., Schmitt, S. K., Askari, M., Kaiser, D. W., Deshmukh, A. J., Heidenreich, P. A., Swan, C., Narayan, S. M., Wang, P. J., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.054 · Cited by 66
Piccini, J. P., PASSMAN, R. S., Turakhia, M. P., Connolly, A. T., Nabutovsky, Y., & Varma, N. (2018) · EP Europace · doi:10.1093/europace/euy222 · Cited by 64
Atrial fibrillation: an emerging epidemic?
Steinberg, J. S. (2004) · Heart · doi:10.1136/hrt.2003.014720 · Cited by 64
Bahit, M. C., Lópes, R. D., WOJDYLA, D. M., Hohnloser, S. H., Alexander, J. H., Lewis, B. S., Aylward, P. E., Verheugt, F. W. A., Keltai, M., Díaz, R., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.062 · Cited by 63
Age as a Critical Determinant of Atrial Fibrillation: A Two-sided Relationship
Laredo, M., Waldmann, V., Khairy, P., & Nattel, S. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.007 · Cited by 67
Heart Failure and Tachycardia-Induced Cardiomyopathy
Ellis, E. R., & Josephson, M. E. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0150-z · Cited by 62
Frost, L., Vestergaard, P., Mosekilde, L., & Mortensen, L. S. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.08.024 · Cited by 62
Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling
Takemoto, Y., Ramírez, R. J., Kaur, K., Salvador, O., Ponce‐Balbuena, D., Ramos‐Mondragón, R., Ennis, S. R., Guerrero‐Serna, G., Berenfeld, O., & Jalife, J. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.014 · Cited by 65
Obesity and cardiovascular risk
Kotsis, V., Tsioufis, K. P., Antza, C., Seravalle, G., Coca, A., Sierra, C., Lurbe, E., Stabouli, S., Jelaković, B., Redón, J., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001731 · Cited by 66
Yue, C., Yang, F., Li, F., & Chen, Y. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111508 · Cited by 64
Stump, G. L., Wallace, A. A., Regan, C. P., & Lynch, J. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092197 · Cited by 61
Epidemiology of atrial fibrillation
Albert, C. M. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12500 · Cited by 61
Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults
Berkovitch, A., Kivity, S., Klempfner, R., Segev, S., Milwidsky, A., Erez, A., Sabbag, A., Goldenberg, I., Sidi, Y., & Maor, E. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.11.016 · Cited by 62
Systematic screening for the detection of atrial fibrillation
Moran, P. S., Teljeur, C., Ryan, M., & Smith, S. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub3 · Cited by 61
Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study
Lin, H., Yin, X., Xie, Z., Lunetta, K. L., Lubitz, S. A., Larson, M. G., Ko, D., Magnani, J. W., Mendelson, M., Liu, C., et al. (2017) · Scientific Reports · doi:10.1038/srep40377 · Cited by 63
Gibbs, H., Freedman, B., Rosenqvist, M., Virdone, S., Mahmeed, W. A., Ambrosio, G., Camm, A., Jacobson, B., Jerjes-Sánchez, C., Kayani, G., et al. (2021) · American Journal of Medicine · doi:10.1016/j.amjmed.2021.01.017 · Cited by 41
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub2 · Cited by 61
Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality.
Bordignon, S., Corti, M. C., & Bilato, C. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.467 · Cited by 71
A KCNQ1 Mutation Causes a High Penetrance for Familial Atrial Fibrillation
Bartos, D. C., Anderson, J. B., Bastiaenen, R., Johnson, J. N., Gollob, M. H., Tester, D. J., Burgess, D. E., Homfray, T., Behr, E. R., Ackerman, M. J., et al. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12068 · Cited by 60
Mitropoulou, C., Fragoulakis, V., Božina, N., Vozikis, A., Šupe, S., Božina, T., Poljaković, Z., van Schaik, R. H., & Patrinos, G. P. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.167 · Cited by 60
Yiu, K., & Tse, H. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.10 · Cited by 58
Pellegrino, P. L., Fassini, G. M., Biase, M. D., & Tondo, C. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12960 · Cited by 60
Johnson, M. E., Lefèvre, C., Collings, S., Evans, D., Kloss, S., Ridha, E., & Maguire, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011471 · Cited by 59
Camm, A. J., Savelieva, I., Ho, S. Y., Lindsay, B. D., Nattel, S., & Shinagawa, K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00044-2 · Cited by 60
Challenges in the classification of atrial fibrillation
Lubitz, S. A., Benjamin, E. J., Ruskin, J. N., Fuster, V., & Ellinor, P. T. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.86 · Cited by 58
How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?
Sankaranarayanan, R., Kirkwood, G. J., Visweswariah, R., & Fox, D. J. (2015) · Current Cardiology Reviews · doi:10.2174/1573403x10666140902143020 · Cited by 63
Ibáñez, L., Sabaté, M., Vidal, X., Ballarín, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Martín‐Merino, E., Montero, D., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14071 · Cited by 58
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
Mascolo, A., Scavone, C., Rafaniello, C., Angelis, A. D., Urbanek, K., di Mauro, G., Cappetta, D., Berrino, L., Rossi, F., & Capuano, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667254 · Cited by 63
A prospective study of supraventricular activity and incidence of atrial fibrillation
Johnson, L., Juhlin, T., Juul‐Möller, S., Hedblad, B., Nilsson, P. M., & Engström, G. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.04.042 · Cited by 58
Naccarelli, G. V., Johnston, S. S., Lin, J., Patel, P. P., & Schulman, K. L. (2010) · Clinical Cardiology · doi:10.1002/clc.20759 · Cited by 58
Sethi, N. J., Nielsen, E. E., Safi, S., Feinberg, J. B., Gluud, C. N., & Jakobsen, J. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193924 · Cited by 59
Park, J. H., Joung, B., Son, N., Shim, J. M., Lee, M., Hwang, C., & Pak, H. (2011) · EP Europace · doi:10.1093/europace/eur135 · Cited by 57
Kolek, M. J., Graves, A. J., Xu, M., Bian, A., Teixeira, P. L., Shoemaker, M. B., Parvez, B., Xu, H., Heckbert, S. R., Ellinor, P. T., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.3366 · Cited by 57
Metadata
- Authors
- Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V.
- Affiliations
- University of South Australia (AU)
- University of Glasgow (GB)
- Corresponding author
- McMurray, John J.V
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 113
- Issue
- 5
- Pages
- 359-364
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1971505725
- Cited by
- 1,562
- References
- 33
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 67 · 2023: 45 · 2022: 64 · 2021: 94 · 2020: 129 · 2019: 88 · 2018: 92 · 2017: 81 · 2016: 100 · 2015: 107 · 2014: 97 · 2013: 85 · 2012: 83
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, long-term morbidity, cardiovascular mortality, stroke, heart failure, sex differences, lone atrial fibrillation, middle-aged adults, cardiovascular hospitalization, all-cause mortality, cardiovascular risk factors, atrial fibrillation risk factors, atrial fibrillation treatment, atrial fibrillation prevention, atrial fibrillation screening
- MeSH terms
- Atrial Fibrillation, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Scotland, Time Factors, Cohort Studies, Survival Rate, Proportional Hazards Models, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
